Sign in

CIK 0001023024 · Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
582301143
Phone
6097591810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,939,756
in 9 filings, $1.9M under 10b5-1 plans

Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lalwani Nikhil −$1.2M PRESIDENT & CEO sold 5% of stake
  2. CAREY STEPHEN P. −$623K SVP & CFO sold 5% of stake
  3. Cook Meredith −$72K SR. VP, GENERAL COUNSEL & SEC. sold 1% of stake
  4. Thoma Jeanne −$72K Director sold 4% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-12 Davis Krista SVP, CHIEF HR OFFICER Grant or award +13,057 62,116
2025-02-12 Davis Krista SVP, CHIEF HR OFFICER Grant or award +8,704 70,820
2025-02-12 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Grant or award 10b5-1 +16,974 72,562
2025-02-12 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Grant or award 10b5-1 +11,316 83,878
2025-02-12 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +14,362 64,041
2025-02-12 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +9,574 73,615
2025-02-12 Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS Grant or award +14,362 83,014
2025-02-12 Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS Grant or award +9,574 92,588
2025-02-12 Mutz Christopher HEAD OF RARE DISEASE Grant or award +24,808 101,585
2025-02-12 Mutz Christopher HEAD OF RARE DISEASE Grant or award +16,538 118,123
2025-02-12 Gutwerg Ori SVP, GENERICS Grant or award +15,668 92,895
2025-02-12 Gutwerg Ori SVP, GENERICS Grant or award +10,444 103,339
2025-02-12 Lalwani Nikhil PRESIDENT & CEO Grant or award +91,399 461,777
2025-02-12 Lalwani Nikhil PRESIDENT & CEO Grant or award +60,932 522,709
2025-02-12 CAREY STEPHEN P. SVP & CFO Grant or award +24,808 179,276
2025-02-12 CAREY STEPHEN P. SVP & CFO Grant or award +16,538 195,814
2025-02-12 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Grant or award +7,834 41,452
2025-02-12 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Grant or award +5,222 46,674
2025-01-13 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sale 10b5-1 −400 $53.92 $22K 55,588
2024-12-17 CAREY STEPHEN P. SVP & CFO Sale −7,500 $55.79 $418K 154,468

Page 10 of 23 · 442 trades